What's happening
This bill allows ambulatory surgery centers for creating and maintaining vascular access for dialysis to operate as end stage renal disease service providers.
Why it matters
Expands treatment options for dialysis patients. by allowing specialized ambulatory surgery centers to perform crucial vascular access procedures, making it easier and potentially faster for patients to get the care needed to begin or maintain dialysis.
May improve patient outcomes and convenience. since procedures for creating and maintaining vascular access could be done in settings designed for efficiency and outpatient care, possibly reducing wait times and hospital burden.
Regulates ownership and oversight. by specifying that corporations and LLCs (not just individuals) can operate these centers, but only if they meet strict experience, quality, and regulatory standards overseen by the health planning council—helping ensure patient safety and care quality.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Expand Kidney Disease Services
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Substituted by A2147
- Advanced to third reading
- 2nd report cal.
- 1st report cal.1044
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Expand Kidney Care Centers
Vetoed · Sponsor Jeffrey Dinowitz
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
149
2023-2024 Regular Sessions
IN SENATE (Prefiled)
January 4, 2023
Introduced by Sen. GIANARIS -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law, in relation to the provision of end stage renal disease services
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Paragraph (a) of subdivision 15 of section 2801-a of the public health law, as amended by chapter 492 of the laws of 2011, is amended to read as follows:
(a) Diagnostic or treatment centers established exclusively to provide end stage renal disease services, including an ambulatory surgery center established exclusively to create and maintain vascular access necessary to dialyze patients with end stage renal disease, may be operated by corporations and limited liability companies formed under the laws of New York whose stockholders or members, as applicable, are not natural persons if such corporations and limited liability companies and its principal stockholders and members, as applicable, and controlling persons comply with all applicable requirements of this section and demonstrate, to the satisfaction of the public health and health planning council, sufficient experience and expertise in delivering high quality end stage renal disease care. For purposes of this subdivision, the public health and health planning council shall adopt and amend rules and regulations, notwithstanding any inconsistent provision of this section, to address any matter it deems pertinent to the establishment and operation of diagnostic or treatment centers pursuant to this subdivision; provided that such rules and regulations shall include, but not be limited to provisions governing or relating to: (i) any direct or indirect changes or transfers of ownership interests or voting rights in such corporations and limited liability companies or their stockholders or members, as applicable, and provide for public health and health
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD01864-01-3
planning council approval of any change in controlling interests, principal stockholders, principal members, controlling persons, parent company or sponsors; (ii) oversight of the operator and its stockholders or members, as applicable, including local governance of the diagnostic or treatment centers; and (iii) relating to the character and competence and qualifications of, and changes relating to, the directors, managers and officers of the operator and its principal stockholders, principal members, controlling persons, parent company or sponsors.
§ 2. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to the provision of end stage renal disease services
Purpose
To clarify that diagnostic and treatment centers established exclusively to provide end stage renal disease services subject to Public Health Law § 2801-a (15)(a) includes ambulatory surgery centers established exclu- sively to create and maintain vascular access necessary to dialyze patients with end stage renal disease.
Summary of provisions
Section one amends paragraph (a) of subdivision 15 of section 2801-a of the public health law to add language that diagnostic and treatment centers established exclusively to provide end stage renal disease services includes ambulatory surgery centers established exclusively to create and maintain vascular access necessary to dialyze patients with end stage renal disease.
Section two sets the effective date.
Existing law
Click here
Justification
Paragraph (a) of subdivision 15 of section 2801-a of the public health law authorizes diagnostic and treatment centers established exclusively to provide end stage renal disease services to be operated by corpo- rations and limited liability companies whose stockholders and members are not natural persons. Inasmuch as life-sustaining hemodialysis treat- ment necessarily depends upon the creation and maintenance of access to the patient's blood stream, end stage renal disease services necessarily includes the creation and maintenance of vascular access for end stage renal disease patients.
This bill will make clear that a diagnostic and treatment center estab- lished exclusively to provide end stage renal disease services includes an ambulatory surgery center established exclusively to create and main- tain vascular access for end stage renal disease patients receiving hemodialysis.
Clarification that dialysis corporations are authorized to establish single-specialty ambulatory surgery centers established exclusively to create and maintain vascular access for hemodialysis patients will facilitate the integration of dialysis treatment and dialysis vascular access. A vascular access integration model has been proven to (1) decrease catheter exposure time consistent with the Centers For Medicare and Medicaid Services (CMS) quality and cost containment goals, (2) increase the use of arteriovenous fistulas ("AVFs") as the preferred method of vascular access for hemodialysis consistent with CMS's Fistula First Initiative, with a concomitant decrease in costs and vascular complication rates, (3) decrease mortality rates, (4) decrease the number of missed dialysis treatments due to access compromise, (5) lower hospital admission rates and inpatient days consistent with DSRIP goals, and (6) decrease overall costs per ESRD patient.
Moreover, this Bill is consistent with CMS' ongoing efforts to reduce the cost, and manage the care of, ESRD patients as reflected in its Comprehensive ESRD Care ("CEC") Model and corresponding ESRD Seamless Care Organizations ("ESCOs") designed to coordinate all care for ESRD beneficiaries.
Legislative history
2022: Passed Senate; Died in Health (Assembly)
2021: Passed Senate; Died in Health (Assembly)
Fiscal implications
None.
Local fiscal implications
Click here
Effective date
Immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.